Candel Therapeutics Shares Halted, News Pending
Portfolio Pulse from Benzinga Newsdesk
Shares of Candel Therapeutics have been halted pending an announcement of news. Investors are awaiting the details of the news that prompted the trading halt.
November 28, 2023 | 2:03 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Candel Therapeutics' shares are currently halted pending news, which indicates a significant announcement that could materially affect the company's stock price.
The trading halt indicates that there is pending news that could be material to Candel Therapeutics' business and stock price. However, without information on the nature of the news, it is not possible to predict the direction of the stock price movement. The score is neutral until the news is released.
CONFIDENCE 50
IMPORTANCE 100
RELEVANCE 100